Rawlins MD .1995 .Pharmacovigilance: Paradise lost, regained or postponed?. The William Withering Lecture 1994. J R Coll Physicians Lond, 29 : 41-9.
LopezG‑onzalez E,Herdeiro MT,Figueiras A .2009 .Determinants of under‑reporting of adverse drug reactions: A systematic review. Drug Saf, 32 : 19-31.
Clark J,Klincewicz S,Stang P .2002 .Overview‑spontaneous s i g n a l l i n g . I n : M a n n R, A n d re w s E , e d i t o r s. Pharmacovigilance. Chichester, : 247-71.
. .‑mc. [Last accessed on 2016 May, 21 : .
Elkalmi RM,Hassali MA,Ibrahim MI,Jamshed SQ,Al‑Lela OQ .2014 .Community pharmacists' attitudes, perceptions, and barriers toward adverse drug reaction reporting in Malaysia: A quantitative insight. J Patient Saf, 10 : 81-7.
Houghton J,Wood F,Davis S,Coulson R .1999 .Community pharmacist reporting of suspected ADRs: (2) Attitude of community pharmacists and general practitioners in Wales. Pharm J, 263 : 788-91.
Generali JA,Danish MA,Rosenbaum SE .1995 .Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists. Ann Pharmacother, 29 : 3659.
Bawazir S. . .Attitude of community pharmacists in Saudi Arabia towards adverse drug reaction reporting. , : .